Cerebral MR Imaging in Uninfected Children Born to HIV-Seropositive Mothers and Perinatally Exposed to Zidovudine

References

1. ↵
   Mofenson L, McIntyre J. Advances and research directions in the prevention of mother to child HIV-1 transmission. Lancet 2000;355:2237–2244

   CrossRefPubMedWeb of Science
2. ↵
   Taylor GP, Low-Beer N. Antiretroviral therapy in pregnancy: a focus on safety. Drug Safety 2001;24:683–702

   CrossRefPubMedWeb of Science
3. ↵
   Culnane M, Fowler M, Lee SS, et al. Lack of long-term effects of in utero exposure to zidovudine among uninfected children born to HIV-infected women: Pediatric AIDS Clinical Trials Group Protocol 219/076 Teams. JAMA 1999;281:151–157

   CrossRefPubMedWeb of Science
4. ↵
   Blanche S, Tardieu M, Rustin P, et al. Persistent mitochondrial dysfunction and perinatal exposure to antiretroviral nucleoside analogues. Lancet 1999;354:1084–1089

   CrossRefPubMedWeb of Science
5. ↵
   The Perinatal Safety review working group. Nucleoside exposure in the children of HIV-infected women receiving antiretroviral drugs: absence of clear evidence for mitochondrial disease in children who died before 5 years of age in five United States cohorts. J Acquir Immune Defic Syndr 2000;25:261–268
6. ↵
   Barret B, Tardieu M, Rustin P, et al. Mitochondrial dysfunction in HIV uninfected children. AIDS 2003;17:1769–1785

   CrossRefPubMedWeb of Science
7. ↵
   Blanche S, Rouzioux C, Moscato ML, et al. A prospective study of infants born to women seropositive for human immunodeficiency virus type 1: HIV Infection in Newborns French Collaborative Study Group. N Engl J Med 1989;320:1643–1648

   CrossRefPubMedWeb of Science
8. ↵
   Nelson JC, Pepe MS. Statistical description of interrater variability in ordinal ratings. Stat Methods Med Res 2000;9:475–496

   Abstract/FREE Full Text
9. ↵
   Filley CM, Kleinschmidt-Demasters BK. Toxic leukoencephalopathy. N Engl J Med 2001;345:425–432

   CrossRefPubMedWeb of Science
10. ↵
    Mantovani A, Calamandrei G. Delayed developmental effects following prenatal exposure to drugs. Curr Pharm Des 2001;7:859–880

    CrossRefPubMed
11. ↵
    Wynn HE, Brundage RC, Fletcher CV. Clinical implications of CNS penetration of antiretroviral drugs. CNS Drugs 2002;16:595–609

    CrossRefPubMedWeb of Science
12. ↵
    Brinkman K, Ter Hofstede HJ, Burger DM, Smeitink JA, Koopmans PP. Adverse effect of reverse transcriptase inhibitors: mitochondrial toxicity as a common path way. AIDS 1998;12:1735–1744

    CrossRefPubMedWeb of Science
13. ↵
    Church JA, Mitchell WG, Gonzalez-Gomez I, et al. Mitochondrial DNA depletion, near fatal metabolic acidosis and liver failure in an HIV infected child treated with combination antiretroviral therapy. J Pediatr 2001;138:748–751

    CrossRefPubMedWeb of Science
14. ↵
    Loutfy MR, Walmsley SL. Treatment of HIV infection in pregnant women: antiretroviral management options. Drugs 2004;64:471–488

    CrossRefPubMedWeb of Science
15. ↵
    Venerosi A, Calamendrei G, Alleva E. Animal models of antiHIV drugs exposure during pregnancy: effect on neurobehavioral development. Prog Neuropsychopharmacol Biol Psychiatry 2002;26:747–761

    CrossRefPubMed
16. ↵
    Gerschenson M, Erhart SW, Paik CY, et al. Fetal mitochondrial heart and skeletal muscle damage in Erythrocebus patas monkeys exposed in utero to 3′-azido-3′-deoxythymidine. AIDS Res Hum Retroviruses 2000;16:635–644

    CrossRefPubMedWeb of Science
17. ↵
    Ewings EL, Gerschenson M, St Claire MC, et al. Genotoxic and functional consequences of transplacental zidovudine exposure in fetal monkey brain mitochondria. J Acquir Immune Defic Syndr 2000;24:100–105
18. ↵
    Gerschenson M, Nguyen V, Ewings EL, et al. Mitochondrial toxicity in fetal Erythrocebus patas monkeys exposed transplacentally to zidovudine + lamivudine. AIDS Res Huma Retroviruses 2004;20:91–100

    CrossRef
19. ↵
    Alimenti A, Burdge D, Ogilvie A, et al. Lactic acidemia in HIV infants exposed to perinatal antiretroviral therapy. Pediatr Inf Dis J 2003;22:782–789

    PubMedWeb of Science
20. ↵
    Shiramizu B, Shikuma KM, Kanemoto L, et al. Placenta and cord blood mitochondrial DNA toxicity in HIV-infected women receiving nucleoside reverse transcriptase inhibitors during pregnancy. J Acquir Immune Defic Syndr 2003;32:370–374
21. ↵
    Poirier MC, Divi RL, Al-Harti L, et al. Long-term mitochondrial toxicity in HIV-uninfected infants born to HIV-infected mothers. J Acquir Immune Defic Syndr 2003;33:175–183
22. ↵
    Uusimaa J, Remes AM, Rantala H, et al. Childhood encephalopathies and myopathies: a prospective study in a defined population to assess the frequency of mitochondrial disorders. Pediatrics 2000;105:598–603

    Abstract/FREE Full Text
23. ↵
    Darin N, Oldfors A, Mosleni AR, Holme E, Tulinius M. The incidence of mitochondrial encephalomyopathies in childhood: clinical features and morphological biochemical and DNA abnormalities. Ann Neurol 2001;49:377–383

    CrossRefPubMedWeb of Science
24. ↵
    Valanne L, Ketonen L, Majander A, et al. Neuroradiologic findings in children with mitochondrial disorders. AJNR Am J Neuroradiol 1998;19:369–377

    Abstract
25. Munoz A, Mateos F, Simon R, et al. Mitochondrial diseases in children: neuroradiological and clinical features in 17 patients. Neuroradiology 1999;41:920–928

    CrossRefPubMedWeb of Science
26. Arii J, Tanabe Y. Leigh syndrome: serial MR imaging and clinical follow-up. AJNR Am J Neuroradiol 2000;21:1502–1509

    Abstract/FREE Full Text
27. ↵
    de Lonlay-Debeney P, Von Kleist-Retzow JC, Hertz-Pannier L, et al. Cerebral white matter disease in children may be caused by mitochondrial respiratory chain deficiency. J Pediatr 2000;136:209–214

    CrossRefPubMedWeb of Science
28. ↵
    Ulmer S, Flemming K, Hahn A, Stephani U, Jansen O. Detection of acute cytotoxic changes in progressive neuronal degeneration of childhood with liver disease (Alpers-Huttenlocher syndrome) using diffusion-weighted MRI and MR spectroscopy. J Comput Assist Tomogr 2002;26:641–646

    CrossRefPubMed
29. ↵
    Abe K, Yoshimura H, Tanaka H, Fujita N, Hikita T, Sakoda S. Comparison of conventional and diffusion-weighted MRI and proton MR spectroscopy in patients with mitochondrial encephalomyopathy, lactic acidosis, and stroke-like events. Neuroradiology 2004;46:113–7

    CrossRefPubMedWeb of Science